BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 25184864)

  • 1. Influenza vaccination of pregnant women and protection of their infants.
    Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
    N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial.
    Nunes MC; Cutland CL; Jones S; Hugo A; Madimabe R; Simões EA; Weinberg A; Madhi SA;
    JAMA Pediatr; 2016 Sep; 170(9):840-7. PubMed ID: 27380464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.
    Nunes MC; Cutland CL; Dighero B; Bate J; Jones S; Hugo A; van Niekerk N; Kuwanda L; Izu A; Weinberg A; Madhi SA;
    J Infect Dis; 2015 Dec; 212(12):1976-87. PubMed ID: 26080370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.
    Mutsaerts E; Madhi SA; Cutland CL; Jones S; Hugo A; Trenor S; Treurnicht FK; Klipstein-Grobusch K; Weinberg A; Nunes MC
    Expert Rev Vaccines; 2016 Aug; 15(8):1055-62. PubMed ID: 27212228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial.
    Nunes MC; Cutland CL; Moultrie A; Jones S; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Weinberg A; Madhi SA;
    Lancet HIV; 2020 Feb; 7(2):e91-e103. PubMed ID: 31911146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.
    Madhi SA; Nunes MC; Weinberg A; Kuwanda L; Hugo A; Jones S; van Niekerk N; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Cutland CL;
    Clin Infect Dis; 2017 Jun; 64(12):1773-1779. PubMed ID: 28369198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial.
    Vesikari T; Virta M; Heinonen S; Eymin C; Lavis N; Chabanon AL; Gresset-Bourgeois V
    Hum Vaccin Immunother; 2020 Mar; 16(3):623-629. PubMed ID: 31526225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial.
    Nunes MC; Cutland CL; Jones S; Downs S; Weinberg A; Ortiz JR; Neuzil KM; Simões EAF; Klugman KP; Madhi SA
    Clin Infect Dis; 2017 Oct; 65(7):1066-1071. PubMed ID: 28575286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness.
    Dhar N; Kwatra G; Nunes MC; Cutland C; Izu A; Nachbagauer R; Krammer F; Madhi SA
    Clin Infect Dis; 2020 Aug; 71(4):1072-1079. PubMed ID: 31565750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials.
    Omer SB; Clark DR; Madhi SA; Tapia MD; Nunes MC; Cutland CL; Simões EAF; Aqil AR; Katz J; Tielsch JM; Steinhoff MC; Wairagkar N;
    Lancet Respir Med; 2020 Jun; 8(6):597-608. PubMed ID: 32526188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
    DiazGranados CA; Dunning AJ; Kimmel M; Kirby D; Treanor J; Collins A; Pollak R; Christoff J; Earl J; Landolfi V; Martin E; Gurunathan S; Nathan R; Greenberg DP; Tornieporth NG; Decker MD; Talbot HK
    N Engl J Med; 2014 Aug; 371(7):635-45. PubMed ID: 25119609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA
    Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
    Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
    Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study.
    Hu Y; Chu K; Lavis N; Li X; Liang B; Liu S; Shao M; Shu JD; Tabar C; Samson S
    Hum Vaccin Immunother; 2019; 15(5):1066-1069. PubMed ID: 30779689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies.
    Adegbola R; Nesin M; Wairagkar N
    Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S28-32. PubMed ID: 22920055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
    Mcbride WJH; Abhayaratna WP; Barr I; Booy R; Carapetis J; Carson S; De Looze F; Ellis-Pegler R; Heron L; Karrasch J; Marshall H; Mcvernon J; Nolan T; Rawlinson W; Reid J; Richmond P; Shakib S; Basser RL; Hartel GF; Lai MH; Rockman S; Greenberg ME
    Vaccine; 2016 Sep; 34(41):4991-4997. PubMed ID: 27595443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.
    Steinhoff MC; Katz J; Englund JA; Khatry SK; Shrestha L; Kuypers J; Stewart L; Mullany LC; Chu HY; LeClerq SC; Kozuki N; McNeal M; Reedy AM; Tielsch JM
    Lancet Infect Dis; 2017 Sep; 17(9):981-989. PubMed ID: 28522338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.
    Sullender WM; Fowler KB; Gupta V; Krishnan A; Ram Purakayastha D; Srungaram Vln R; Lafond KE; Saha S; Palomeque FS; Gargiullo P; Jain S; Lal R; Widdowson MA; Broor S
    Lancet Glob Health; 2019 Jul; 7(7):e940-e950. PubMed ID: 31200893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.